Identification of filamin C as a new physiological substrate of PKBalpha using KESTREL.


We detected a protein in rabbit skeletal muscle extracts that was phosphorylated rapidly by PKBa (protein kinase Ba), but not by SGK1 (serum- and glucocorticoid-induced kinase 1), and identified it as the cytoskeletal protein FLNc (filamin C). PKBa phosphorylated FLNc at Ser2213 in vitro, which lies in an insert not present in the FLNa and FLNb isoforms. Ser2213 became phosphorylated when C2C12 myoblasts were stimulated with insulin or epidermal growth factor, and phosphorylation was prevented by low concentrations of wortmannin, at which it is a relatively specific inhibitor of phosphoinositide 3-kinase. PD 184352 [an inhibitor of the classical MAPK (mitogen-activated protein kinase) cascade] and/or rapamycin [an inhibitor of mTOR (mammalian target of rapamycin)] had no effect. Insulin also induced the phosphorylation of FLNc at Ser2213 in cardiac muscle in vivo, but not in cardiac muscle that does not express PDK1 (3-phosphoinositide-dependent kinase 1), the upstream activator of PKB. These results identify the muscle-specific isoform FLNc as a new physiological substrate for PKB.

6 Figures and Tables

Citations per Year

173 Citations

Semantic Scholar estimates that this publication has 173 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Murray2004IdentificationOF, title={Identification of filamin C as a new physiological substrate of PKBalpha using KESTREL.}, author={James T. Murray and David G. Campbell and Mark Peggie and Alfonso Mora and Philip Cohen}, journal={The Biochemical journal}, year={2004}, volume={384 Pt 3}, pages={489-94} }